Skip to main content
. 2008 May;98(5):839–845. doi: 10.2105/AJPH.2006.101915

TABLE 2—

Hepatitis B Virus Immunization and Infection Among 2834 Men Who Have Sex With Men, by Demographic Characteristics, Access to Health Care, and Risk Behaviors: Young Men’s Survey Phase 2, 1998–2000

No. (%) Hepatitis B Immunization, % (95% CI) HBV Infection,a % (95% CI) HBV Infection, AORb (95% CI)
Total 2834 (100) 17.2 (15.7, 18.4) 20.6 (19.1, 22.1)
Study Sitec,d
    Dallas, TX 459 (16.2) 13.7 (10.8, 17.2) 24.0 (20.1, 27.9) 1.8 (1.3, 2.6)
    New York, NY 533 (18.8) 14.8 (12.0, 18.0) 28.3 (24.2, 31.8) 2.1 (1.4, 2.9)
    Los Angeles, CA (Ref) 436 (15.4) 15.4 (11.6, 18.4) 15.6 (12.6, 19.4) 1.00
    Baltimore, MD 488 (17.2) 16.0 (12.7, 19.3) 17.8 (14.6, 21.4) 1.3 (0.9, 1.9)
    Miami, FL 452 (15.9) 17.0 (13.5, 20.5) 17.5 (13.5, 20.5) 1.3 (0.9, 1.8)
    Seattle, WA 466 (16.4) 26.4 (22.0, 30.0) 19.3 (15.4, 22.6) 1.7 (1.2, 2.5)
Race/ethnicityc,d
    White (Ref) 1395 (49.2) 20.4 (18.2, 22.5) 16.1 (14.2, 18.0) 1.00
    Hispanic 676 (23.9) 13.5 (10.9, 16.1) 21.5 (18.4, 24.6) 1.2 (0.9, 1.6)
    Asian 155 (5.5) 29.0 (21.9, 36.1) 24.5 (17.7, 31.3) 2.5 (1.6, 3.8)
    Black 485 (17.1) 10.1 (7.4, 12.8) 31.6 (27.5, 35.7) 1.7 (1.3, 2.3)
Age,d y
    23–25 (Ref) 1384 (48.8) 18.1 (16.1, 20.1) 14.9 (13.0, 16.8) 1.00
    26–29 1444 (51.0) 16.4 (14.5, 18.3) 26.1 (23.8, 28.4) 2.0 (1.62, 2.5)
Education,c,d y
    < 12 (Ref) 122 (4.3) 9.0 (3.9, 14.1) 35.3 (26.8, 43.8) 1.00
    12 607 (21.4) 10.1 (7.7, 12.5) 28.8 (25.2, 32.4) 1.0 (0.7, 1.6)
    13–15 842 (29.7) 13.8 (11.5, 16.1) 19.6 (16.9, 22.3) 0.7 (0.5, 1.1)
    16 958 (33.8) 21.6 (19.0, 24.2) 17.6 (15.2, 20.0) 0.7 (0.4, 1.1)
    > 17 305 (10.8) 30.2 (25.0, 35.4) 13.1 (9.3, 16.9) 0.5 (0.3, 0.8)
Annual income,d $
    < 20 000 (Ref) 1068 (37.7) 15.2 (13.0, 17.4) 25.2 (22.6, 27.8) 1.00
    > 20 000 1766 (62.3) 18.4 (16.6, 20.2) 18.2 (16.4, 20.0) 0.72 (0.6, 0.9)
Ever had a diagnosis of STDc
    No (Ref) 2074 (73.4) 17.6 (16.0, 19.2) 16.0 (12.0, 20.0) 1.00
    Yes 750 (26.6) 16.0 (13.4, 18.6) 33.2 (27.4, 39.0) 1.9 (1.6, 2.4)
Anti-HIV serologyc,d
    Negative (Ref) 2480 (87.5) 17.9 (16.4, 19.4) 17.1 (13.5, 20.7) 1.00
    Positive 354 (12.5) 12.4 (9.0, 15.8) 45.5 (37.8, 53.2) 2.5 (1.9, 3.3)
Lifetime male partnersd
    1–50 (Ref) 2234 (78.8) 17.6 (16.0, 19.2) 17.9 (16.3, 19.4) 1.00
    ≥ 51 600 (21.2) 15.7 (12.8, 18.6) 31.0 (27.3, 34.7) 1.6 (1.3, 2.1)
Ever had anal intercoursed
    No (Ref) 139 (4.9) 19.4 (12.8, 26.0) 9.4 (4.5, 14.3) 1.00
    Yes 2695 (95.1) 17.1 (15.6, 18.5) 21.2 (19.7, 22.7) 1.9 (1, 3.4)
Ever injected drugsd
    No (Ref) 2632 (92.6) 17.3 (15.9, 8.7) 19.7 (18.2, 21.2) 1.00
    Yes 202 (7.1) 17.2 (12.0, 22.4) 32.7 (26.2, 39.2) 1.5 (1.1, 2.1)
Disclosed sexual orientationc
    To less than half of acquaintances 1890 (67.3) 14.1 (11.8, 16.3) 23.5 (20.8, 26.3)
    To at least half of acquaintances 918 (32.7) 19.0 (17.1, 20.6) 19.4 (17.6, 21.2)
Ever tested for HIVb,d
    No 315 (11.1) 16.2 (12.1, 20.3) 14.9 (10.9, 18.8)
    Yes 2518 (88.8) 17.3 (15.8, 18.8) 21.4 (19.8, 23.0)
Regular source of health careb,c
    None 1040 (36.7) 12.6 (10.6, 14.6) 21.9 (19.4, 24.4)
    Doctor or HMO 1257 (44.4) 21.0 (18.7, 23.3) 17.5 (15.4, 19.6)
    School, company, or military clinic 106 (3.7) 28.3 (19.7, 36.9) 13.2 (6.8, 19.6)
    Public clinic 188 (6.6) 16.5 (11.2, 21.8) 27.1 (20.7, 33.5)
    Hospital or emergency department 208 (7.3) 13.5 (8.9, 18.1) 29.8 (23.6, 36.0)

Note. CI = confidence interval; AOR = adjusted odds ratio; STD = sexually transmitted disease; HMO = health maintenance organization. Hepatitis B immunization was determined by the presence of antibodies to HBV surface antigen in the absence of other seromarkers. HBV-prevalent infection was defined as the presence of HBV surface antigen or antibody to HBV core antigen.

aTotal number of men who have sex with men tested = 2829; 5 participants did not have hepatitis B virus (HBV) surface antigen test results.

bBecause this logistic model was estimating odds of ever being infected with HBV given potential exposures or risk behaviors, variables related to healthcare access were not included in the model. AORs are presented only for variables that remained significant in the final logistic models.

cSignificant differences existed (P < .05) in univariate analysis of immunization levels.

dSignificant differences existed (P < .05) in univariate analysis of HBV infection levels.